Abstract
Abelson murine leukaemia virus (A-MuLV) is a replication-defective retrovirus capable of rapid in vivo and in vitro transformation of bone marrow lymphoid target cells. A-MuLV was isolated from a steroid treated BALB/c mouse inoculated with the replication competent Moloney-MuLV (M-MuLV)1–4. The A-MuLV genome (5.5 kilobases) retains regions of precise homology to M-MuLV at its 5′ end (1,320 bases) and 3′ end (730 bases). The centre of the A-MuLV genome (3,500 bases) is non-homologous to M-MuLV and presumably represents unique sequences derived from the mouse genome by a recombinational event5. The only known protein encoded by the A-MuLV genome is one of MW 120,000, called P120 (refs 6, 7). About one-quarter of this protein is encoded by the 5′-terminal M-MuL V-related sequences and the rest is encoded by the A-MuLV unique sequences. P120 has been found in all cell lines transformed by the strain of A-MuLV that originally derived from ANN-1 cells2, including transformed non-producer cells. P120 can be translated in vitro using A-MuLV genomic RNA as messenger RNA. P120 is a phosphoprotein but there is no evidence for glycosylation6,8,9. We have used an anti-A-MuLV syngeneic tumour regressor serum with defined specificities to search for cross-reacting normal cellular proteins. We have identified a protein of MW 150,000 (NCP150) in metabolically labelled thymus and other lymphoid organs. NCP150 by absorption and competition analysis is closely related to the unique region of the A-MuLV P120 protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abelson, H. T. & Rabstein, L. S. Cancer Res. 30, 2208–2212 (1970).
Scher, C. D. & Siegler, R. Nature 253, 729–731 (1975).
Rosenberg, N., Baltimore, D. & Scher, C. D. Proc. natn. Acad. Sci. U.S.A. 72, 1932–1936 (1975).
Rosenberg, N. & Baltimore, D. J. exp. Med. 143, 1453–1463 (1976).
Shields, A. thesis, M.I.T., Cambridge, Mass. (1979).
Witte, O. N., Rosenberg, N., Paskind, M., Shields, A. & Baltimore, D. Proc. natn. Acad. Sci. U.S.A. 75, 2488–2492 (1978).
Reynolds, F. H., Sacks, T. L., Deobagkar, D. H. & Stephenson, J. R. Proc. natn. Acad. Sci. U.S.A. 75, 3974–3978 (1978).
Reynolds, F. H., van de Ven, W. J. M. & Stephenson, J. R. J. Virol. 28, 665–670 (1978).
Witte, O. N., Rosenberg, N. & Baltimore, D. J. Virol. (in the press).
Witte, O. N. & Baltimore, D. J. Virol. 26, 750–761 (1978).
Collett, M. S., Brugge, J. S. & Erikson, R. L. Cell 15, 1363–1369 (1978).
Oppermann, H., Levinson, A. D., Varmus, H. E., Levintow, L. & Bishop, J. M. Proc. natn. Acad. Sci. U.S.A. 76, 1804–1808 (1979).
Spector, D. H. et al. Cell 13, 371–379 (1978).
Risser, R., Stockert, E. & Old, L. J. Proc. natn. Acad. Sci. U.S.A. 75, 3918–3922 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Witte, O., Rosenberg, N. & Baltimore, D. A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product. Nature 281, 396–398 (1979). https://doi.org/10.1038/281396a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/281396a0
This article is cited by
-
Chromosome translocations: dangerous liaisons revisited
Nature Reviews Cancer (2001)
-
The evolution of small DNA viruses of eukaryotes: Past and present considerations
Virus Genes (1995)
-
Immunocytochemical evaluation abl-Gene products in Leukemic Cell Lines
Medical Oncology and Tumor Pharmacotherapy (1990)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.